How many employees does Immunome, Inc. have?

Immunome, Inc. reported 177 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 3, 2026. That is up 50.0% from a year earlier.

What is Immunome, Inc.'s revenue per employee?

Immunome, Inc. brought in $6.9M of revenue in fiscal Dec 2025, which is $39K per employee. That ranks 38 of 39 companies we track in Biotechnology, where the median is $602K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Immunome, Inc. employees and revenue per employee

IMNM · Biotechnology · $2.19B market cap

Immunome, Inc. had 177 employees at the end of fiscal Dec 2025, up 50.0% from a year earlier. Revenue for the year was $6.9M, down 23.2% from a year earlier, or $39K per employee. Revenue fell while headcount grew.

Employees

177

+50.0% YoY

Revenue

$6.9M

-23.2% YoY

Revenue / employee

$39K

Peer median $602K

Rank in industry

38 of 39

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2023

Hover a year for the numbers.

IMNM employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	177	$6.9M	$39K	+50.0%	-23.2%
Dec 2024	118	$9.0M	$77K	+114.5%	-35.5%
Dec 2023	55	$14.0M	$255K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Immunome, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
AMLX Amylyx Pharmaceuticals, Inc.	123	$87.4M	$710K	Contracting
PTGX Protagonist Therapeutics, Inc.	132	$46.0M	$349K	Hiring into decline
NUVB Nuvation Bio Inc.	298	$62.9M	$211K	Efficient growth
KYMR Kymera Therapeutics, Inc.	238	$39.2M	$165K	Hiring into decline
RLAY Relay Therapeutics, Inc.	192	$15.4M	$80K	Leaner
PRAX Praxis Precision Medicines, Inc.	116	$8.6M	$74K	Efficient growth
PGEN Precigen, Inc.	160	$9.7M	$61K	Efficient growth
IMNM Immunome, Inc.	177	$6.9M	$39K	Hiring into decline
CRNX Crinetics Pharmaceuticals, Inc.	594	$7.7M	$13K	Efficient growth

Every Healthcare company

Questions about Immunome, Inc.

How many employees does Immunome, Inc. have?: Immunome, Inc. reported 177 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 3, 2026. That is up 50.0% from a year earlier.
What is Immunome, Inc.'s revenue per employee?: Immunome, Inc. brought in $6.9M of revenue in fiscal Dec 2025, which is $39K per employee. That ranks 38 of 39 companies we track in Biotechnology, where the median is $602K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare IMNM with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Immunome, Inc.'s annual reports (Form 10-K), latest filed March 3, 2026. This is data, not a recommendation to buy or sell IMNM.